High-density lipoproteins:an emerging target in the prevention of cardiovascular disease

被引:4
|
作者
Belinda A Cutri
Neil J Hime
Stephen J Nicholls
机构
[1] Australia
[2] Department of Immunology
[3] Department of Cardiovascular Medicine
[4] The Scripps Research Institute
[5] USA
[6] OH 44195
[7] Mail Code JJ65
[8] 9500 Euclid Avenue
[9] The Cleveland Clinic Foundation
[10] The Heart Research Institute Camperdown
[11] Sydney
[12] La Jolla
[13] CA 92037
[14] NSW 2050
关键词
high-density lipoproteins; cardiovascular disease; atherosclerotic plaque; stabilises lesions;
D O I
暂无
中图分类号
R54 [心脏、血管(循环系)疾病];
学科分类号
1002 ; 100201 ;
摘要
High-density lipoproteins (HDLs) have been well established to protect against the development of atheroscleroticcardiovascular disease.It has become apparent that in addition to the promotion of reverse cholesterol transport,HDLspossess a number of additional functional properties that may contribute to their beneficial influence on the arterial wall.A number of exciting therapeutic strategies have been developed that target HDL and its ability to protect against thedevelopment of atherosclerotic plaque.This paper will review how the promotion of the functional properties of HDLinhibits the formation of atherosclerotic plaque and stabilises lesions in patients with established disease.
引用
收藏
页码:799 / 808
页数:10
相关论文
共 50 条
  • [1] High-density lipoproteins: an emerging target in the prevention of cardiovascular disease
    Cutri, Belinda A.
    Hime, Neil J.
    Nicholls, Stephen J.
    CELL RESEARCH, 2006, 16 (10) : 799 - 808
  • [2] High-density lipoproteins: an emerging target in the prevention of cardiovascular disease
    Belinda A Cutri
    Neil J Hime
    Stephen J Nicholls
    Cell Research, 2006, 16 : 799 - 808
  • [3] High-density lipoproteins: A new potential therapeutic target for the prevention of cardiovascular disease
    Brewer, HB
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (03) : 387 - 391
  • [4] High-density lipoproteins: a therapeutic target for atherosclerotic cardiovascular disease
    Gomaraschi, Monica
    Calabresi, Laura
    Franceschini, Guido
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (04) : 561 - 572
  • [5] High-density lipoproteins: a novel therapeutic target for cardiovascular disease
    Saleem, T. S. Mohamed
    Rani, P. V. Sandhya
    Gauthaman, K.
    RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2011, 2 : 1 - 6
  • [6] High-Density Lipoproteins in the Prevention of Cardiovascular Disease: Changing the Paradigm
    Tuteja, S.
    Rader, D. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (01) : 48 - 56
  • [7] Emerging role of high-density lipoprotein in the prevention of cardiovascular disease
    Brousseau, ME
    DRUG DISCOVERY TODAY, 2005, 10 (16) : 1095 - 1101
  • [8] High-density lipoproteins as an emerging therapeutic target for atherosclerosis
    Rader, DJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (17): : 2322 - 2324
  • [9] High-density lipoproteins: Marker of cardiovascular risk and therapeutic target
    Toth, Peter P.
    Davidson, Michael H.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (05) : 359 - 364
  • [10] Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease
    Zewinger, Stephen
    Kleber, Marcus E.
    Rohrer, Lucia
    Lehmann, Marlene
    Triem, Sarah
    Jennings, Richard T.
    Petrakis, Ioannis
    Dressel, Alexander
    Lepper, Philipp M.
    Scharnagl, Hubert
    Ritsch, Andreas
    Thorand, Barbara
    Heier, Margit
    Meisinger, Christa
    Gala, Tonia de las Heras
    Koenig, Wolfgang
    Wagenpfeil, Stefan
    Schwedhelm, Edzard
    Boger, Rainer H.
    Laufs, Ulrich
    von Eckardstein, Arnold
    Landmesser, Ulf
    Luscher, Thomas F.
    Fliser, Danilo
    Marz, Winfried
    Meinitzer, Andreas
    Speer, Thimoteus
    EUROPEAN HEART JOURNAL, 2017, 38 (20) : 1597 - 1607